Breast Pathology Flashcards

1
Q

First off list 5 benign breast conditions

A
  1. Fibrocystic change
  2. Fibroadenoma
  3. Intraductal papilloma
  4. Fat necrosis
  5. Duct Ectasia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is a fibroadenoma and who gets it?

A

Proliferation of the epithelial and stromal elements leads to a circumscribed mobile, non-painful nodule.

Occurs in women of reproductive age, peaking at 3rd decade May regress with age if left untreated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

When would we suspect fat necrosis?

A

If it looks clinically and on mammogram like a carcinoma PLUS they have a h/o trauma or surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What benign conditions commonly cause nipple discharge?

A

Intraduct Papillomas and Duct Ectasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Name a breast condition that can be benign and malignant?

A

Phyllodes tumour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is a Phyllodes tumour?

A

A fibroepithelial fleshy tumour (leaf like pattern) cysts on its cut surface

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How many women get and die from breast carcinoma?

A

1 in 8 women (22% of all female cancers)

1 in 3 affected women die of it

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How does a carcinoma of the breast look clinically?

A

A hard fixed mass that tethers to the skin

With “orange peel” skin dimpling (peau d’orange)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Where does breast carcinoma spread to?

A
  1. Locally to skin and pecs
  2. Lymphatically to axillary and internal mammary nodes
  3. By blood to bones, lungs, liver and brain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What tests can we do to identify a breast carcinoma?

A
  • Clinical examination
  • Radiology (Mammogram, ultrasound, MRI)
  • Fine needle aspiration cytology FNA
  • Needle core biopsy
  • Wide local excision with adequate margins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

We histologically classify breast carcinoma into Non-invasive (in situ) and Invasive. What are the subtypes of carcinoma in-situ?

A

Ductal Carcinoma in-situ (DCIS)

Lobular Carcinoma in-situ (LCIS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Carcinoma in-situ is pre-invasive so non-palpable and can’t be detected clinically, how do we find it then?

A

On breast cancer screening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How do we determine the risk a non-invasive carcinoma will become invasive?

A

By its grade, which requires biopsy.

Low grade DCIS - 30% in 15yrs

High Grade DCIS - 50% in 8yrs

LCIS - 19% in 25yrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the subtypes of invasive carcinoma of breast and which is the most common?

A
  • Invasive Ductal Carcinoma 85%
  • Invasive Lobular Carcinoma 10%
  • Special 5% (tubular, mucinous and medullary)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What do we use to estimate prognosis for breast carcinoma, and what factors is it based on?

A

The Nottingham Prognostic Index (NRI)

Uses size, grade and nodal status

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Whats the 5yr survival for breast cancer?

A

64% mean 5yr survival

17
Q

How do we determine if a breast carcinoma will respond to hormonal therapies?

A

Check if its Oestrogen receptor or Progesterone receptor +VE (ER/PR)

18
Q

What are the risk factors for breast carcinoma?

A
  • Gender
  • Age
  • Early Menarche
  • Older age of first pregnancy
  • FH and H/O
  • Radiation
  • Hormonal treatment
  • Obesity
  • Alcohol
  • Genetic Factors
19
Q

What are the major genetic risk factors for breast carcinoma?

A

BRCA1 or BRCA2

20
Q

What options do we have for managing breast cancer?

A
  • Surgery (mastectomy, breast conserving surgery – WLE) +lymph nodes
  • Radiotherapy
  • Antihormonal therapy (Tamoxifen)
  • Chemotherapy
21
Q

What is Paget’s disease of the nipple?

A

An intraepithelial spread of intraductal carcinoma

It leads to large pale-staining cells in the epidermis of the nipple

22
Q

How does Paget’s disease of nipple present?

A
  • Pain and itching
  • Scaling
  • Redness
  • It’s easily mistaken for eczema
  • You may see ulcers, crusting and serous or bloody discharge
23
Q

What are the major male pathologies of the breast?

A

Carcinoma (very rare)

Gynaecosmastia (actually quite common)

24
Q

What can cause gynaecomastia?

A
  • Hyperthyroidism
  • Cirrhosis
  • Chronic renal or pulmonary disease
  • Hypogonadism
  • Certain medications e.g. hormone therapies, spironolactone, Tricyclic Antidepressants
25
Q

What are other types of adenomas?

A

Tubular adenoma

  • Far less common than fibroadenomas
  • Young women, discrete, freely movable masses
  • Uniform sized ducts

Lactating Adenoma

  • Enlarging masses during lactation or pregnancy
  • Prominent secretory change
26
Q

What are the features of a carcinoma in situ?

A
  • Pre-invasive: non palpable so not detected clinically
  • Multicentral
  • Bilateral
  • No metastatic spread as in basement membrane
  • Risk of invasion depending on grading
27
Q

What does a mammogram detect?

A

Masses and microcalcifications

28
Q

What are microcalcifications?

A

Tiny deposits of calcium can appear anywhere in the breast and often show up on a mammogram

  • Most women have one or more areas of microcalcifications of various sizes
  • Majority of calcium deposits are harmless
  • A small percentage may be in precancerous or cancerous tissue
29
Q

What does prognosis depend on?

A
  • Patient related and tumour related
  • Node status (best prognostic indicator)
  • Tumour size ( < 2cm)
  • Type - Grade (1,2,3 )
  • Age
  • Lymphovascular space invasion
  • Oestrogen receptors ( ER )
  • Progesterone receptors ( PR )
  • HER-2
  • Proliferative rate of tumour
  • Gene expression profiling
  • Nottingham Prognostic Index ( NPI ) based on tumour size, grade and nodal status